Clinical trials
Thrombosis clinical trials
Below are recruiting thrombosis clinical trials, each written for real people, not researchers. We’re tracking 179 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06007872Recruiting
Heart device implant using ultrasound probe inside the heart
This trial studies a procedure to implant a Watchman device using a tiny ultrasound probe placed inside the heart, avoiding a probe in the throat. It may help patients with atrial fibrillation who need to reduce stroke risk.
Cleveland, OhioAges 18 years+ - NCT06051032Recruiting
Comparing balloon vs. suction for clotted dialysis fistulas
This study compares two ways to clear a sudden clot in a dialysis fistula (AVF). It uses either a balloon (to push the clot out) or a suction device (to pull the clot out) to restore blood flow.
Valencia, ValenciaAges 18 years+ - NCT06075602Recruiting
Complex and calcified coronary artery disease: a registry study
This study watches how people with complex or calcified heart artery disease are treated (with stents or bypass surgery) and how they do over time. It aims to learn which treatments work best for tough blockages.
Lucerne, Canton of LucerneAges 18 years+ - NCT06113510Recruiting
Clot imaging for heart attacks with clear arteries
This study uses a special type of MRI to look for tiny blood clots in the heart arteries that may have caused a heart attack even when standard tests show no major blockages. It aims to better understand the cause of heart attacks in people with this uncommon pattern.
EdinburghAges 18 years+ - NCT06166576RecruitingPhase 2
Radioembolization for Liver Cancer with Vein Involvement
This trial tests a targeted radiation treatment (radioembolization) for liver cancer that has grown into the main vein (portal vein) but is still limited to one lobe of the liver. It is for people who have not received any prior cancer treatment and whose liver function is still fairly good.
Ilsan, Gyeonggi-doAges 18 years+ - NCT06195540RecruitingPhase 3
Rivaroxaban versus LMWH for leg injuries needing a cast
This trial compares two blood thinners (rivaroxaban pills versus LMWH shots) to see which is better at preventing blood clots in people with leg injuries that require a cast or brace. If you qualify, you can receive one of these treatments while your leg heals.
AgenAges 18 years+ - NCT06308952RecruitingPhase 4
Atorvastatin before flow diverter for brain aneurysms
This trial tests whether taking atorvastatin before a flow diverter procedure can prevent strokes or other brain events in people with unruptured brain aneurysms. It may help reduce complications from the treatment.
Guangzhou, GuangdongAges 18–75 - NCT06347276Recruiting
PFO closure and brain microemboli study
This trial looks at whether closing a small hole in the heart (PFO) can reduce tiny clots traveling to the brain. It includes people who have had a stroke or migraine, and also those without symptoms but with high-risk features.
Beijing, Beijing MunicipalityAges 18–65 - NCT06348459Recruiting
Catheter treatment for severe pulmonary embolism
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
Madrid, MadridAges 18 years+ - NCT06357403Recruiting
Predicting blood clots in ICU patients with a blood test
This study looks at whether a blood test measuring a substance called anti-factor Xa activity can help predict dangerous blood clots in critically ill patients. If you join, researchers will follow you to see if the test results can prevent clots.
Graz, StyriaAges 18 years+ - NCT06365528Recruiting
Tunneled PICC line in adults in the hospital
This study looks at how well a tunneled PICC (a special long-term IV line) works in adults who need it while in the hospital. It aims to see if it reduces complications compared to standard PICCs, which could mean fewer problems for you.
Porto AlegreAges 18 years+ - NCT06385353Recruiting
First leg clot size and long-term risk
This study looks at how the size and location of a first-time leg blood clot affects the risk of long-term problems like chronic pain or swelling. You may join if you have a new, symptomatic clot in one leg and haven't had one before.
Vichy, AllierAges 18 years+ - NCT06393764Recruiting
Blood clots in cancer patients: a long-term study
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
BrestAges 18–80 - NCT06417541Recruiting
Study of blood clots from central lines using CT scans
This study uses special CT scans (photon-counting CT) to look for blood clots related to central lines, both in patients who have passed away and in living patients. It aims to better understand and detect these clots.
Lund, Skåne CountyAges 18 years+ - NCT06451003Recruiting
Preventing blood clots after cancer surgery: a program trial
This trial tests a program to help people who had cancer surgery get medicine to prevent dangerous blood clots. If you had belly or pelvic cancer surgery and are not on blood thinners, you may be able to join.
Charleston, South CarolinaAges 18 years+ - NCT06451575Recruiting
Blood Clots and Behçet's Disease Study
This study looks at how Behçet's disease affects blood clotting. If you have Behçet's disease and are between 18–70, you may help doctors understand why some people with Behçet's develop dangerous blood clots.
Erzurum, Üniversite MahallesiAges 18–70 - NCT06480994Recruiting
Testing a new tool to help diagnose blood clots
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
Niort, SartresAges 18 years+ - NCT06498323RecruitingPhase 4
Comparing TNK vs TPA for stroke in a mobile unit
This trial compares two clot-busting medicines, TNK and TPA, given through an IV in a special ambulance (Mobile Stroke Unit) to treat acute ischemic stroke. The goal is to see which drug works better when started quickly after symptoms begin.
BangkokAges 18 years+ - NCT06519292Recruiting
Heart side effects from immunotherapy in cancer patients
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
Amsterdam, North HollandAges 50 years+ - NCT06519435Recruiting
Blood flow check for leg vein blockages with gentle pressure
This study uses a device that gently presses on your calf to check blood flow in leg veins, along with an ultrasound you already had. It may help doctors better understand vein blockages.
Rochester, MinnesotaAges 18 years+ - NCT06523959RecruitingPhase 4
Blood clot prevention in abdominal or pelvic surgery
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
HelsinkiAges 18 years+ - NCT06552767Recruiting
Thrombosis and blood vessel inflammation study
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
Bethesda, MarylandAges 5–100 - NCT06559475Recruiting
Testing a new aspiration catheter for large vessel stroke
This trial tests a new catheter (Super-Bore 8/7F) to remove blood clots in people having a major stroke caused by a blocked large artery in the brain. The goal is to see if it is safe and effective at restoring blood flow when used within 24 hours of stroke symptoms starting.
Hefei, AnhuiAges 18 years+ - NCT06658197RecruitingPhase 3
Comparing a new clot-busting drug for severe stroke
This study tests a medication called tenecteplase, given before a procedure to remove a large blood clot in the brain. It may help people who have had a severe stroke within the last 4.5 hours.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for thrombosis?
- Yes. Clin2 currently lists 179 recruiting thrombosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a thrombosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a thrombosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.